Blog

A recent study explores the potential of psilocybin, the active ingredient in magic mushrooms, to restore fear extinction and help in treating post-traumatic stress disorder (PTSD). The research focuses on how psilocybin can increase neuroplasticity in the hippocampus, a brain region associated with memory formation and fear extinction. 

PTSD is a mental health condition triggered by traumatic events, leading to symptoms like flashbacks, nightmares, and severe anxiety. While many individuals recover from PTSD symptoms over time, some experience persistent and debilitating effects due to impaired “fear extinction.” This process involves learning that certain previously traumatic stimuli pose no immediate threat. 

MICE PAVING THE WAY FOR PTSD TREATMENT

Research indicates that individuals with PTSD often have a smaller hippocampus and reduced neuroplasticity in this region, which is crucial for memory processes. The study led by Dr. Liming Zhang and Dr. Guyan Wang from China aims to investigate whether psilocybin could restore fear extinction in these patients. 

Psilocybin is recognized as a “breakthrough therapy” for depression, a common comorbidity with PTSD. Previous studies have shown that psilocybin promotes neuronal growth and the formation of new synapses, potentially explaining its antidepressant effects. This led the research team to hypothesize that psilocybin could enhance fear extinction by increasing neuroplasticity in the hippocampus. 

The researchers conducted experiments using mice to test their theory. They induced a fear response in the mice by pairing a neutral stimulus (a 5 kHz tone) with an aversive stimulus (an electric shock to the feet). This conditioned the mice to freeze in fear when they heard the tone. Some of the fear-conditioned mice were then administered a single dose of psilocybin and received fear reduction training, which included 12 fear resolution training sessions. 

The results showed that the psilocybin-treated mice exhibited significantly improved fear extinction compared to the untreated ones. To understand the mechanisms behind this improvement, the researchers analyzed the mice’s brains. They discovered that the dendrites in the hippocampi of psilocybin-treated mice resembled those of control mice, while untreated mice experienced a decline in dendritic complexity and density. Psilocybin also reversed the decline in proteins associated with neuroplasticity and fear extinction. 

STEPPING STONE FOR HUMAN TREATMENT

This study offers valuable insights into the potential therapeutic effects of psilocybin on the brain. Currently, only two drugs are approved for PTSD treatment, and they come with limited efficacy and severe side effects. The findings suggest that psilocybin could be a promising alternative treatment for PTSD, which is a significant step forward in improving the available treatment options. 

In conclusion, the research underscores the potential of psilocybin in promoting fear extinction and treating PTSD by enhancing neuroplasticity in the hippocampus. While the study was conducted on mice, it provides a strong foundation for future clinical studies, offering hope for individuals struggling with PTSD and a possible breakthrough in treatment for this challenging condition.

Our findings suggest promising potentials of psilocybin for treatment of PTSD at the preclinical level and provide impetus for future clinical studies. But, it is not clear in which receptor psilocybin plays its role in facilitating fear extinction, which is worth further study.

Dr. Wang